Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Shares of Oracle Corporation ORCL rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fiscal third quarter.

Oracle’s third-quarter revenue increased 7% year-over-year to $13.3 billion, which missed the consensus estimate of $13.306 billion, according to Benzinga Pro. The company reported quarterly earnings of $1.41 per share, which beat average estimates of $1.38 per share.

Oracle shares jumped 13.4% to $129.46 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

  • Singularity Future Technology Ltd. SGLY gained 88.6% to $5.94 in pre-market trading after gaining over 6% on Monday.
  • Nukkleus Inc. NUKK shares rose 87.8% to $2.16 in pre-market trading after surging over 43% on Monday.
  • ClearOne, Inc. CLRO rose 74.4% to $1.58 in pre-market trading. ClearOne announced a special one-time cash dividend of 50 cents per share.
  • Assure Holdings Corp. IONM gained 49.6% to $0.49 in pre-market trading. Assure Holdings entered into an agreement to sell certain of its assets to MPOWERHealth for up to $4.5 million.
  • Gaucho Group Holdings, Inc. VINO climbed 31.4% to $0.71 in pre-market trading.
  • Heritage Insurance Holdings, Inc. HRTG shares gained 24.6% to $8.91 in pre-market trading following better-than-expected fourth-quarter results.
  • Nexalin Technology, Inc. NXL shares gained 18.7% to $0.5010 in pre-market trading after falling 12% on Monday. Nexalin Technology recently announced results of a clinical study of its Gen-2 tACS device for the treatment of chronic insomnia.
  • ATRenew Inc. RERE gained 15.1% to $1.37 in pre-market trading after the company reported fourth-quarter results and announced a $20 million share repurchase program.
  • MINISO Group Holding Limited MNSO shares gained 15% to $20.61 in pre-market trading after posting stronger-than-expected quarterly earnings.

Losers

  • Renalytix Plc RNLX fell 19.3% to $0.92 pre-market trading after gaining around 5% on Monday. Renalytix recently received an unsolicited acquisition approach from a large, publicly-listed strategic diagnostics company and is evaluating an acquisition of the entire issued, and to be issued, the share capital of the company.
  • CytomX Therapeutics, Inc. CTMX shares dipped 18.3% to $2.05 in pre-market trading following fourth-quarter results.
  • ACADIA Pharmaceuticals Inc ACAD fell 17.4% to $19.93 in pre-market trading after the company reported the Phase 3 ADVANCE-2 trial evaluating pimavanserin for the treatment of negative symptoms of schizophrenia did not meet the primary endpoint.
  • Finch Therapeutics Group, Inc. FNCH dipped 16.5% to $2.85 in pre-market trading after jumping over 36% on Monday.
  • Snow Lake Resources Ltd. LITM fell 13% to $0.80 pre-market trading after declining around 6% on Monday.
  • Solidion Technology Inc. STI fell 12.6% to $1.53 in pre-market trading after jumping 124% on Monday.
  • Safe and Green Development Corporation SGD declined 12.1% to $1.02 in pre-market trading after falling over 6% on Monday.
  • Kidpik Corp. PIK shares tumbled 10.8% to $4.34 after surging 80% on Monday.
  • Marpai, Inc. MRAI shares tumbled 10.2% to $1.76 in pre-market trading after gaining over 11% on Monday. Marpai shares are trading higher after the company reported better-than-expected preliminary Q4 net revenue results. Also, the company announced an "Off-Cycle" new client agreement.
  • Ocular Therapeutix, Inc. OCUL shares fell 5.9% to $9.16 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.

 

Now Read This: Kohl's, Oracle And 3 Stocks To Watch Heading Into Tuesday

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!